ArticleOncotarget2017

Inhibitor of H3K27 demethylase JMJD3/UTX GSK-J4 is a potential therapeutic option for castration resistant prostate cancer.

Viacheslav M Morozov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.